The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients

Table 3

The multivariate linear regression model of factors associated with Hct change in HD patients after treatment of CERA in the 1st and 4th week respectively.

Hct change in the 1st week	B estimate	𝑃 value	𝑟^2=0.408
Ferritin (for each 1 ng/mL increase)*	0.002	0.0002
Na (for each 1 mEq/L increase)*	0.170	0.003
Total protein (for each 1 g/dL increase)*	1.084	0.009
Total bilirubin (for each 1 mg/dL increase)*	2.564	0.012
Platelet (for each 1 10^3/μL increase)	−0.0047	0.292
Hct change in the 4th week	B estimate	𝑃 value	𝑟^2=0.215
LDL (for each 1 mg/dL increase)*	−0.041	0.0004
CRP > 4 mg/dL or not*	−0.193	0.047

*For 𝑃<0.05.
B, unstandardized regression beta coefficient; Na = sodium; LDL, low density lipoprotein; CRP, C-reactive protein.